| Cardiomyopathy |
1 |
1 |
| Heart |
0 |
0.76 |
| Cardiovascular Imaging |
0 |
0.67 |
| Coronary Artery Disease (CAD) |
0 |
0.63 |
| Clinical Guidelines |
0 |
0.38 |
| Ischemic Cardiomyopathy |
0 |
0.38 |
| Ejection Fraction |
0 |
0.32 |
| Europe |
0 |
0.14 |
| Infarction |
0 |
0.14 |
| Acute Myocardial Infarction (MI) |
0 |
0.13 |
| Acute Coronary Syndrome |
0 |
0.1 |
| Artery |
0 |
0.09 |
| Grant |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| Quality of Life |
0 |
0.09 |
| Stenosis |
0 |
0.09 |
| Percutaneous Coronary Intervention |
0 |
0.08 |
| Myocardial Infarction (MI) |
0 |
0.07 |
| Beta-Adrenergic Agonist |
0 |
0.05 |
| Diversity |
0 |
0.05 |
| Echocardiography |
0 |
0.05 |
| Jobs |
0 |
0.05 |
| Kansas |
0 |
0.05 |
| Left Ventricular Dysfunction |
0 |
0.05 |
| New York |
0 |
0.05 |
| SGLT2 Inhibitor |
0 |
0.05 |
| Stress |
0 |
0.05 |
| Transplantation |
0 |
0.05 |
| Angina Pectoris |
0 |
0.04 |
| Social Determinants of Health |
0 |
0.04 |
| Type 2 Diabetes Mellitus |
0 |
0.04 |